CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
Methylprednisolone, 20 mg +3 moredrug
Likely dose
Methylprednisolone, 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02242630
NCT02242630N/ACompleted
CompareCT.gov

Improvement in Function and Pain Due to Subacromial Bursitis in Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone

Keesler Air Force Base Medical Center·interventional·Posted Sep 17, 2014·Updated Dec 14, 2016

In Brief

A clinical study evaluating Methylprednisolone, 20 mg, Methylprednisolone, 40 mg, and 2 other interventions for Subacromial Bursitis and Shoulder Pain. Completed, enrolled 61 participants across 1 site.

Detailed Summary

It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whether 20 mg or 40 mg of either triamcinolone or methylprednisolone significantly affect improvement in shoulder pain 6 weeks after injection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubacromial Bursitis, Shoulder Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 17, 2014
Enrollment StartSep 1, 2014
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 11.8 years ago

Interventions

Methylprednisolone, 20 mgdrug

Compared with intrabursal triamcinolone

Methylprednisolone, 40 mgdrug

Compared with intrabursal triamcinolone

Triamcinolone, 20 mgdrug

Compared with methylprednisolone

Triamcinolone, 40 mgdrug

Compared with methylprednisolone